Control of Mycobacterium tuberculosis infection in the elderly: Is there a role for epigenetic reprogramming reversal?

• Published in: BioFactors (Oxford) Vol. 51; no. 1; p. e2151
• Main Authors: Romero-Rodríguez, Dámaris P, Díaz-Alvarado, Carlos A, Rocha-González, Héctor Isaac, Juárez, Esmeralda
• Format: Journal Article
• Language: English
• Published: Netherlands 01.01.2025
• Subjects: Adaptive Immunity; Aged; Aging - genetics; Aging - immunology; Epigenesis, Genetic; Humans; Immunity, Innate; Immunomodulation; Immunosenescence; Inflammation - genetics; Inflammation - immunology; Mycobacterium tuberculosis - drug effects; Mycobacterium tuberculosis - immunology; Mycobacterium tuberculosis - pathogenicity; Tuberculosis - drug therapy; Tuberculosis - genetics; Tuberculosis - immunology; Tuberculosis - microbiology; Tuberculosis - prevention & control; epigenetic reprogramming; immunosenescence; trained immunity; elderly; tuberculosis
• ISSN: 1872-8081
• DOI: 10.1002/biof.2151

With the increase in the elderly population worldwide, the number of subjects suffering from tuberculosis (TB) has shown an increased prevalence in this group. Immunosenescence is essential in this phenomenon because it may reactivate the lesions and render their adaptive immunity dysfunctional. In addition, inflammation in the lungs of the elderly subjects is also dysfunctional. Although effective drugs are available, they are often tolerated inadequately, reducing adherence to the therapy and leading to therapeutic failure. Comorbidities, poor general health status, and other medications may lead to increased drug adverse reactions and reduced adherence to treatment in the elderly. Hence, older adults require an individualized approach for better outcomes. Trained immunity, which involves epigenetic reprogramming, may contribute to balancing the dysfunction of innate and adaptive immunity in older people. This review analyzes the relationship between inflammation, age, and Mycobacterium tuberculosis. Moreover, we hypothesize that immunomodulation using trained immunity activators will help reduce inflammation while enhancing antimicrobial responses in the elderly. Understanding immunomodulation's molecular and physiological effects will lead to informed decisions about TB prevention and treatment strategies uniquely designed for the elderly.